Advaxis Inc. [NASDAQ: ADXS] closed the trading session at $0.47 on 04/21/21. The day’s price range saw the stock hit a low of $0.441, while the highest price level was $0.4849. The company report on April 12, 2021 that Advaxis, Inc. Announces $20 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules.
Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, announced it has entered into definitive agreements with two healthcare-focused, institutional investors for the purchase of (i) 17,577,400 shares of common stock, (ii) 7,671,937 pre-funded warrants (the “Pre-Funded Warrants”) to purchase 7,671,937 shares of common stock and (iii) registered common share purchase warrants to purchase 11,244,135 shares of common stock. The Company has also agreed to issue to the investors, in a concurrent private placement, unregistered common share purchase warrants to purchase 14,005,202 shares of the Company’s common stock. Each share of common stock and accompanying common share purchase warrant are being sold together at a combined offering price of $0.7921, and each Pre-funded Warrant and accompanying common warrant are being sold together at a combined offering price of $0.7911, pursuant to a registered direct offering, priced at-the-market under Nasdaq rules. The Pre-Funded Warrants are immediately exercisable, at an exercise price of $0.001, and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full. The registered common share purchase warrants will have an exercise price of $0.70 per share, will be immediately exercisable, and will expire five (5) years from the date of issuance. The unregistered common share purchase warrants will have an exercise price of $0.70 per share, will be exercisable fourteen days after the Company increases its authorized share capital, and will expire five (5) years from their initial exercise date (collectively, the “Offering”).
The Company plans to use the net proceeds from the offering to fund its continued research and development initiatives in connection with expanding its product pipeline including, but not limited to, investment in its ADXS-HOT program and for general corporate purposes. The Company may also use a portion of the net proceeds to acquire or invest in other businesses, products and technologies.
The stocks have a year to date performance of 35.42 percent and weekly performance of -16.72 percent. The stock has been moved at 2.65 percent over the last six months. The stock has performed -43.96 percent around the most recent 30 days and changed -31.76 percent over the most recent 3-months.
If compared to the average trading volume of 10.21M shares, ADXS reached to a volume of 6434438 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Advaxis Inc. [ADXS]:
Barclays have made an estimate for Advaxis Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on August 03, 2016. While these analysts kept the previous recommendation, Barclays raised their target price to Overweight. The new note on the price target was released on September 22, 2015, representing the official price target for Advaxis Inc. stock. Previously, the target price had yet another raise to $30, while Guggenheim analysts kept a Buy rating on ADXS stock. On June 16, 2015, analysts increased their price target for ADXS shares from 25 to 30.
The Average True Range (ATR) for Advaxis Inc. is set at 0.06, with the Price to Sales ratio for ADXS stock in the period of the last 12 months amounting to 37.73. The Price to Book ratio for the last quarter was 1.05, with the Price to Cash per share for the same quarter was set at 0.22.
ADXS stock trade performance evaluation
Advaxis Inc. [ADXS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -16.72. With this latest performance, ADXS shares dropped by -43.96% in over the last four-week period, additionally plugging by 2.65% over the last 6 months – not to mention a drop of -22.59% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ADXS stock in for the last two-week period is set at 29.54, with the RSI for the last a single of trading hit 23.80, and the three-weeks RSI is set at 35.12 for Advaxis Inc. [ADXS]. The present Moving Average for the last 50 days of trading for this stock 0.8166, while it was recorded at 0.4734 for the last single week of trading, and 0.5642 for the last 200 days.
Advaxis Inc. [ADXS]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Advaxis Inc. [ADXS] shares currently have an operating margin of -9337.55. Advaxis Inc.’s Net Margin is presently recorded at -10462.06.
Return on Total Capital for ADXS is now -62.39, given the latest momentum, and Return on Invested Capital for the company is -70.80. Return on Equity for this stock declined to -75.94, with Return on Assets sitting at -63.18. When it comes to the capital structure of this company, Advaxis Inc. [ADXS] has a Total Debt to Total Equity ratio set at 19.94. Additionally, ADXS Total Debt to Total Capital is recorded at 16.62, with Total Debt to Total Assets ending up at 15.62. Long-Term Debt to Equity for the company is recorded at 16.75, with the Long-Term Debt to Total Capital now at 13.97.
Reflecting on the efficiency of the workforce at the company, Advaxis Inc. [ADXS] managed to generate an average of -$1,470,500 per employee.Advaxis Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 9.90 and a Current Ratio set at 9.90.
Earnings per share (EPS) analysis for Advaxis Inc. [ADXS] stock
With the latest financial reports released by the company, Advaxis Inc. posted -0.15/share EPS, while the average EPS was predicted by analysts to be reported at -0.31/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 51.60%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ADXS.
Advaxis Inc. [ADXS]: Insider Ownership positions
There are presently around $5 million, or 12.80% of ADXS stock, in the hands of institutional investors. The top three institutional holders of ADXS stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 6,069,343, which is approximately 85.826% of the company’s market cap and around 0.06% of the total institutional ownership; BLACKROCK INC., holding 870,007 shares of the stock with an approximate value of $0.41 million in ADXS stocks shares; and VANGUARD GROUP INC, currently with $0.38 million in ADXS stock with ownership of nearly 0% of the company’s market capitalization.
Positions in Advaxis Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 20 institutional holders increased their position in Advaxis Inc. [NASDAQ:ADXS] by around 4,343,166 shares. Additionally, 7 investors decreased positions by around 364,666 shares, while 13 investors held positions by with 6,216,089 shares. The mentioned changes placed institutional holdings at 10,923,921 shares, according to the latest SEC report filing. ADXS stock had 11 new institutional investments in for a total of 1,066,264 shares, while 3 institutional investors sold positions of 224,430 shares during the same period.